Article

Deep learning from HE slides to predict the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer

2020-12-10

Abstract excerpt

<h4>Background: </h4> The predictive value of adjuvant chemotherapy for early-stage hormone receptor-positive breast cancer has been only validated by a 21-gene expression assay. We hypothesized that deep-learning prediction from HE images, called Lunit-SCOPE, is a potential prognostic and predictive biomarker of adjuvant chemotherapy. <h4>Methods: </h4>: We retrospectively collected HE slides from 1153 de-identif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eed15ddf-5280-5178-af14-976ddfd31515
DOI: 10.21203/rs.3.rs-118010/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Deep learning from HE slides to predict the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancerDOI 10.21203/rs.3.rs-118010/v1Read

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitSemantic proximity Read

Prediction of OncotypeDX recurrence score using H&E stained WSI imagesSemantic proximity Read

Assessing the risk of recurrence in early-stage breast cancer through H&E stained whole slide imagesSemantic proximity Read

Deep learning can predict prognosis and endocrine therapy response in breast cancer patients from H&E staining based on estrogen receptor signaling activitySemantic proximity Read

Multimodal Prediction of Breast Cancer Recurrence Assays and Risk of RecurrenceSemantic proximity Read

Multimodal histopathologic models stratify hormone receptor-positive early breast cancerSemantic proximity Read

Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerSemantic proximity Read

Estrogen Receptor Gene Expression Prediction from H&E Whole Slide ImagesSemantic proximity Read

HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancerSemantic proximity Read

Estimated survival outcomes and absolute chemotherapy treatment benefit using PREDICT Tool® and EndoPredict®, in hormone-positive early-stage breast cancer.Semantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read